Diet and gut bacteria in pancreatic cancer treatment
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how diet and the bacteria in your gut might affect how well chemotherapy works for pancreatic cancer that can be surgically removed. If you have been newly diagnosed with this type of pancreatic cancer, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older and willing to sign a consent form
- Has pancreatic ductal adenocarcinoma (a common type of pancreatic cancer)
- The cancer is either removable with surgery or likely removable after some chemotherapy
- Has not already received chemotherapy for this pancreatic cancer
- Has no other active cancer that requires treatment with medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a three-drug chemotherapy combination (gemcitabine, cisplatin, and nab-paclitaxel) given before surgery for people with pancreatic cancer that can be removed or is on the edge of being removable. The goal is to shrink the tumor and improve surgery outcomes.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
This trial is testing a combination of three chemotherapy drugs (NALIRIFOX) given before surgery to shrink borderline resectable pancreatic cancer. The goal is to help make surgery more successful and improve outcomes.
This study tailors standard chemotherapy for pancreatic cancer based on whether the tumor has a change in the SMAD4 gene. The goal is to see if a specific treatment plan works better for each gene type.
This trial tests whether a special MRI scan can help doctors better plan treatment for people with pancreatic cancer that is borderline able to be removed by surgery. The study will check how the tumor responds to initial treatment before surgery.
This research study looks at how your body's chemistry, immune system, and gut bacteria interact during treatment for advanced pancreatic cancer that cannot be removed by surgery. Researchers will collect blood and stool samples to analyze these factors, hoping to better understand responses to therapy.
Hear when a new Borderline Resectable Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.